U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386887) titled 'Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer' on April 15.
Brief Summary: The goal of this clinical trial is to see if timed fasting (periods of time that you don't eat) in participants who are receiving chemotherapy prior to surgery is achievable, safe and can improve quality of life, symptoms and outcomes (results) compared to participants who receive standard dietary recommendations in individuals being treated for epithelial ovarian cancer . The main questions it aims to answer are:
* Is it feasible to use intermittent fasting during neoadjuvant chemotherapy?
* Is it safe to use intermitte...